News
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (24)
- Nov (34)
- Dec (20)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Featured news
Latest news
An experimental new CAR-T therapy shows high efficacy in multiple myeloma, even against treatment resistance
A study led by the Clínic-IDIBAPS concludes that antidepressants may be safe in bipolar disorder
Hospital Clínic ranks among the world’s best smart and specialized hospitals according to Newsweek
Apheresis: donation and therapeutic use
Apheresis is a medical procedure by which specific components of a person’s blood are removed and the rest is returned to the bloodstream through one1
A new CAR-T therapy shows efficacy in preclinical models of hard-to-treat leukemias
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a stud1
A multicenter study identifies the differentiated risk of colorectal cancer depending on the affected gene in Lynch syndrome
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic mut1
The MigraAgile project allows for innovative migraine care in coordination with Primary Care
The digital project MigraAgile, promoted by the Hospital Clínic Barcelona in collaboration with the Primary Care Centres of the Barcelona Esquerra In1
A new epigenetic methodology makes it possible to reconstruct the evolution of cancer and anticipate its clinical progression
An international team led by the Clínic-IDIBAPS and the Institute of Cancer Research in London has developed an innovative new method based on DNA me1